Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Jan:11 Suppl:169-77.
doi: 10.1093/jac/11.suppl_a.169.

The interactions of [14C]cefotetan with penicillin binding proteins of a wide variety of Gram-positive and gram-negative species

The interactions of [14C]cefotetan with penicillin binding proteins of a wide variety of Gram-positive and gram-negative species

R D Nolan et al. J Antimicrob Chemother. 1983 Jan.

Abstract

Membrane preparations were made from a number of Gram-positive and Gram-negative bacterial strains. The ability of the membrane-bound penicillin-binding proteins (PBP) in these preparations to bind [14C]cefotetan has been studied. Increasing amounts of unlabelled benzylpenicillin were added and subsequently [14C]cefotetan was introduced to determine its ability to bind to additional proteins or to displace the pre-bound benzylpenicillin. In the Gram-positive series some quantitative binding differences between the two labelled compounds could be seen. However, in the majority of Gram-negative organisms tested cefotetan exhibited greatest affinity for PBP 3 and none for PBP 2. No new PBPs were detected using [14C]cefotetan, suggesting that the compound exerts its antibacterial effect by a mechanism similar to the other cephamycins. The high minimal inhibitory concentrations (MICs) of cefotetan found for the Gram-positive genera tested are reflected in only one organism by the failure to bind of some of its PBPs. In the majority of cases, permeability is assumed to play the dominant role in the relatively low sensitivity of these organisms to cefotetan.

PubMed Disclaimer